CMC Requirements for New Drug Registration in Latin America
ISPE
MAY 9, 2023
In addition to the COR, some Latin American markets require approval in the COO, which is defined as the country where the drug is manufactured, packaged, or exported from. Sometimes, COAs for the drug substance, the excipients used in the formulation, and the primary and nonfunctional secondary packaging material are requested.
52 
Let's personalize your content